SecBot SecBot
SECBOTREPLAY Home › Report › BIIB

BIIB · Biogen issued a preliminary earnings update for Q1 2026, expecting a…

BIOGEN INC. · 8-K filed Apr 6, 2026 at 06:31 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Apr 6, 2026 at 06:31 ET

Biogen issued a preliminary earnings update for Q1 2026, expecting a $34 million charge for acquired in-process R&D and milestone expenses, impacting EPS by approximately $0.19 per share. This is a forward-looking estimate ahead of final results.

  • Biogen expects a $34 million pre-tax charge for acquired in-process R&D, upfront, and milestone expenses in Q1 2026.
  • The charge is expected to reduce both GAAP and non-GAAP diluted EPS by approximately $0.19 per share.
  • Final results for Q1 2026 are not yet finalized and remain subject to closing procedures.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access